Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience.

Uchiike, Akihiro; Kono, Haruka; Miura, Katsuhiro; Hayama, Tatsuya; Tsutsumi, Daisuke; Tsuboi, Shinya; Ohtsuka, Susumu; Hidaka, Shinji

Uchiike, Akihiro; Kono, Haruka; Miura, Katsuhiro; Hayama, Tatsuya; Tsutsumi, Daisuke; Tsuboi, Shinya; Ohtsuka, Susumu; Hidaka, Shinji.

Afiliação

Uchiike A; Nihon University Itabashi Hospital Tumor Center, 30-1 Oyaguchikamicho, Itabashi, 173-8610, Tokyo, Japan.
Kono H; Department of Pharmacy, Nihon University Itabashi Hospital, Tokyo, Japan.
Miura K; Department of Pharmaceutical Regulatory Science, School of Pharmacy, Nihon University, Chiba, Japan.
Hayama T; Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
Tsutsumi D; Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan.
Tsuboi S; Nihon University Itabashi Hospital Tumor Center, 30-1 Oyaguchikamicho, Itabashi, 173-8610, Tokyo, Japan. miura.katsuhiro@nihon-u.ac.jp.
Ohtsuka S; Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan. miura.katsuhiro@nihon-u.ac.jp.
Hidaka S; Nihon University Itabashi Hospital Tumor Center, 30-1 Oyaguchikamicho, Itabashi, 173-8610, Tokyo, Japan.

J Pharm Health Care Sci ; 9(1): 24, 2023 Aug 01.

Article em En | MEDLINE | ID: mdl-37525281

Palavras-chave

Chemotherapy-induced nausea; Highly emetogenic chemotherapy; Olanzapine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Revista: J Pharm Health Care Sci Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google